Back
Novo Nordisk AS Vs. Nutanix Industry Stock Comparison
Sell
34
NONOF
Novo Nordisk AS
Last Price:
102.84
Seasonality Move:
10.92%
Buy
83
NTNX
Nutanix
Last Price:
70.92
Seasonality Move:
15.64%
Sell
34
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NONOF] share price is $105.49. The Score for NONOF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
83
Nutanix (NTNX)
is a Buy
Is Nutanix a Buy, Sell or Hold?
- The current Nutanix [NTNX] share price is $69.44. The Score for NTNX is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- NTNX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $105.49
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.96 | Sell |
| Relative Strength Index (14 RSI): | 42.96 | Sell |
| Chaikin Money Flow: | 32377 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.78 - 115) | Sell |
| Bollinger Bands (100): | (113.85 - 136.93) | Sell |
NTNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.11 | Buy |
| Relative Strength Index (14 RSI): | 60.65 | Buy |
| Chaikin Money Flow: | 1579653 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.2 - 69.86) | Buy |
| Bollinger Bands (100): | (51.71 - 65.19) | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 104.24 | Buy |
| 20-day SMA: | 108.18 | Sell |
| 50-day SMA: | 116.71 | Sell |
| 200-day SMA: | 127.84 | Sell |
| 8-day EMA: | 104.48 | Buy |
| 20-day EMA: | 107.97 | Sell |
| 50-day EMA: | 115.05 | Sell |
| 200-day EMA: | 120.69 | Sell |
NTNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.36 | Sell |
| 20-day SMA: | 66.95 | Buy |
| 50-day SMA: | 63.33 | Buy |
| 200-day SMA: | 59.87 | Buy |
| 8-day EMA: | 69.27 | Buy |
| 20-day EMA: | 67.5 | Buy |
| 50-day EMA: | 63.98 | Buy |
| 200-day EMA: | 57.33 | Buy |
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Nutanix Earnings Growth & NTNX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $0.24 per share.
Novo Nordisk AS Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nutanix Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||